December 28, 2011
ALS TDI Teams with Two Biotechs to Develop Therapy
The MDA-supported ALS Therapy Development Institute (ALS TDI) will collaborate with Biogen Idec and UCB to test CDP7657, a compound that modulates the immune system
Article Highlights:
• CDP7657 is an antibody fragment that...